Malaria prevention study for Kenyan schoolchildren
Part of Blood & lymphatic, Infections clinical trials.
This study tests different schedules of a malaria prevention medicine to see which works best for improving school attendance, learning, and executive function in children aged 6 to 10 in Siaya County, Kenya.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 6 and 10 years old.
- Your child is enrolled in a participating primary school in Siaya County, Kenya.
- Your family lives in the school's area and plans to stay for the study duration.
- You (parent or guardian) can give informed consent, and your child agrees to participate.
- Your child is willing to follow study procedures and attend follow-up visits.
- Your child does not have certain health conditions like heart problems, severe anemia, or a recent malaria treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if giving schoolchildren malaria-prevention medicine at certain times can lower malaria in the community. It might help protect your child and others from getting sick.
This study aims to find the best way to treat or prevent malaria in children with HIV. It may also help children without HIV who live in areas where malaria is common.
This study looks at how malaria spreads in Mozambique by testing children and pregnant women with fever. If you or your child may have malaria, participating could help researchers understand and fight the disease better.
This study tests a new combination of three malaria drugs in healthy adults to see how safe they are and how the body handles them. It helps find the right dose for future patients.
This trial tests a long-acting mosquito repellent that could help prevent malaria. It is for children living in the study area, and simply involves letting us know if your child is home for a visit.
This Phase 3 trial tests whether giving malaria medicine to people in high-risk households (a “mass drug administration” campaign) can stop local relapses and eliminate vivax malaria. If you live close to a recent malaria case, you may be offered a preventive dose, based on age and medical safety checks.
Hear when a new Malaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.